Cyclic oligomers (macroaldonolactones) from a protected d-galactonic acid monomer

Dicyclohexylcarbodiimide-promoted self-condensation of 2,3:4,5-di-O-isopropylidene-d-galactonic acid (3) led to the macrocyclic oligomeric cyclo[(2,3:4,5-di-O-isopropylidene-(1→6)-d-galactonate)2 ] (4) and cyclo[(2,3:4,5-di-O-isopropylidene-(1→6)-d-galactonate)3 ] (5), having, respectively, 14- and...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lorena Romero Zaliz, C., Varela, O.
Formato: JOUR
Materias:
Acceso en línea:http://hdl.handle.net/20.500.12110/paper_00404039_v50_n40_p5677_LorenaRomeroZaliz
Aporte de:
id todo:paper_00404039_v50_n40_p5677_LorenaRomeroZaliz
record_format dspace
spelling todo:paper_00404039_v50_n40_p5677_LorenaRomeroZaliz2023-10-03T14:50:56Z Cyclic oligomers (macroaldonolactones) from a protected d-galactonic acid monomer Lorena Romero Zaliz, C. Varela, O. Aldonic acid Biomaterial Cyclodextrin Macrocycle Macrolactone 2,3:4,5 di o isopropylidene dextro galactonic acid biomaterial cyclo[(2,3:4,5 di o isopropylidene 2(1-6) dextro galactonate)] cyclo[(2,3:4,5 di o isopropylidene 3(1-6) dextro galactonate)] cyclodextrin galactonic acid lactone derivative macroaldonolactone derivative macrocyclic compound oligomer unclassified drug article cyclization dimerization oligomerization proton nuclear magnetic resonance reaction analysis synthesis Dicyclohexylcarbodiimide-promoted self-condensation of 2,3:4,5-di-O-isopropylidene-d-galactonic acid (3) led to the macrocyclic oligomeric cyclo[(2,3:4,5-di-O-isopropylidene-(1→6)-d-galactonate)2 ] (4) and cyclo[(2,3:4,5-di-O-isopropylidene-(1→6)-d-galactonate)3 ] (5), having, respectively, 14- and 21-membered rings. The macrocycles 4 and 5 were also synthesized by cyclization of the respective linear dimer 11 and trimer 14 ω-hydroxy acids precursors prepared by stepwise additions of 3. Compounds 4 and 5 are biomaterials that may be described as macrolactone-cyclodextrins. © 2009 Elsevier Ltd. All rights reserved. JOUR info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/2.5/ar http://hdl.handle.net/20.500.12110/paper_00404039_v50_n40_p5677_LorenaRomeroZaliz
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic Aldonic acid
Biomaterial
Cyclodextrin
Macrocycle
Macrolactone
2,3:4,5 di o isopropylidene dextro galactonic acid
biomaterial
cyclo[(2,3:4,5 di o isopropylidene 2(1-6) dextro galactonate)]
cyclo[(2,3:4,5 di o isopropylidene 3(1-6) dextro galactonate)]
cyclodextrin
galactonic acid
lactone derivative
macroaldonolactone derivative
macrocyclic compound
oligomer
unclassified drug
article
cyclization
dimerization
oligomerization
proton nuclear magnetic resonance
reaction analysis
synthesis
spellingShingle Aldonic acid
Biomaterial
Cyclodextrin
Macrocycle
Macrolactone
2,3:4,5 di o isopropylidene dextro galactonic acid
biomaterial
cyclo[(2,3:4,5 di o isopropylidene 2(1-6) dextro galactonate)]
cyclo[(2,3:4,5 di o isopropylidene 3(1-6) dextro galactonate)]
cyclodextrin
galactonic acid
lactone derivative
macroaldonolactone derivative
macrocyclic compound
oligomer
unclassified drug
article
cyclization
dimerization
oligomerization
proton nuclear magnetic resonance
reaction analysis
synthesis
Lorena Romero Zaliz, C.
Varela, O.
Cyclic oligomers (macroaldonolactones) from a protected d-galactonic acid monomer
topic_facet Aldonic acid
Biomaterial
Cyclodextrin
Macrocycle
Macrolactone
2,3:4,5 di o isopropylidene dextro galactonic acid
biomaterial
cyclo[(2,3:4,5 di o isopropylidene 2(1-6) dextro galactonate)]
cyclo[(2,3:4,5 di o isopropylidene 3(1-6) dextro galactonate)]
cyclodextrin
galactonic acid
lactone derivative
macroaldonolactone derivative
macrocyclic compound
oligomer
unclassified drug
article
cyclization
dimerization
oligomerization
proton nuclear magnetic resonance
reaction analysis
synthesis
description Dicyclohexylcarbodiimide-promoted self-condensation of 2,3:4,5-di-O-isopropylidene-d-galactonic acid (3) led to the macrocyclic oligomeric cyclo[(2,3:4,5-di-O-isopropylidene-(1→6)-d-galactonate)2 ] (4) and cyclo[(2,3:4,5-di-O-isopropylidene-(1→6)-d-galactonate)3 ] (5), having, respectively, 14- and 21-membered rings. The macrocycles 4 and 5 were also synthesized by cyclization of the respective linear dimer 11 and trimer 14 ω-hydroxy acids precursors prepared by stepwise additions of 3. Compounds 4 and 5 are biomaterials that may be described as macrolactone-cyclodextrins. © 2009 Elsevier Ltd. All rights reserved.
format JOUR
author Lorena Romero Zaliz, C.
Varela, O.
author_facet Lorena Romero Zaliz, C.
Varela, O.
author_sort Lorena Romero Zaliz, C.
title Cyclic oligomers (macroaldonolactones) from a protected d-galactonic acid monomer
title_short Cyclic oligomers (macroaldonolactones) from a protected d-galactonic acid monomer
title_full Cyclic oligomers (macroaldonolactones) from a protected d-galactonic acid monomer
title_fullStr Cyclic oligomers (macroaldonolactones) from a protected d-galactonic acid monomer
title_full_unstemmed Cyclic oligomers (macroaldonolactones) from a protected d-galactonic acid monomer
title_sort cyclic oligomers (macroaldonolactones) from a protected d-galactonic acid monomer
url http://hdl.handle.net/20.500.12110/paper_00404039_v50_n40_p5677_LorenaRomeroZaliz
work_keys_str_mv AT lorenaromerozalizc cyclicoligomersmacroaldonolactonesfromaprotecteddgalactonicacidmonomer
AT varelao cyclicoligomersmacroaldonolactonesfromaprotecteddgalactonicacidmonomer
_version_ 1807315646462033920